The DOI matches its Crossref record; 43 of the 43 references it cites were found in a registry or an index.
Broad and strong memory CD4+ and CD8+ T cells induced by SARS-CoV-2 in UK convalescent individuals following COVID-19
Open accessPublished version of a preprint
Abstract
The development of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccines and therapeutics will depend on understanding viral immunity. We studied T cell memory in 42 patients following recovery from COVID-19 (28 with mild disease and 14 with severe disease) and 16 unexposed donors, using interferon-γ-based assays with peptides spanning SARS-CoV-2 except ORF1. The breadth and magnitude of T cell responses were significantly higher in severe as compared with mild cases. Total and spike-specific T cell responses correlated with spike-specific antibody responses. We identified 41 peptides containing CD4+ and/or CD8+ epitopes, including six immunodominant regions. Six optimized CD8+ epitopes were defined, with peptide-MHC pentamer-positive cells displaying the central and effector memory phenotype. In mild cases, higher proportions of SARS-CoV-2-specific CD8+ T cells were observed. The identification of T cell responses associated with milder disease will support an understanding of protective immunity and highlights the potential of including non-spike proteins within future COVID-19 vaccine design.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Using HLA class I and II predicted peptide “megapools,” circulating SARS-CoV-2-specific CD8+ and CD4+ T cells were identified in COVID-19 acute, mild and convalescent patients [110, 118-125].”
From Guidelines for the use of flow cytometry and cell sorting in immunological studies (third edition) (2021) · cites this paper as [120]
Experimental — accuracy not yet measuredIn the citing paper
“By contrast, VAERD has not usually occurred if a TH1 cell-biased CD4+ T cell response is elicited, reflected by increased levels of interferon-γ (IFNγ), IL-2 and tumour necrosis factor (TNF)44–46,49.”
From Immunological mechanisms of vaccine-induced protection against COVID-19 in humans (2021) · cites this paper as [46]
In the citing paper
“Robust CD4+ and CD8+ T cell memory is induced after COVID-19,22,39, 40, 41 and multiple COVID-19 vaccines elicit CD4+ and CD8+ T cell responses.26,42, 43, 44, 45”
From Impact of SARS-CoV-2 variants on the total CD4+ and CD8+ T cell reactivity in infected or vaccinated individuals (2021) · cites this paper as [40]
In the citing paper
“It should be noted that all plasma and sera tested completely inhibited entry at the lowest dilution tested and that T cell responses will contribute to control of SARS-CoV-2 infection, particularly in re-infected convalescent patients (Grifoni et al., 2020; Peng et al., 2020).”
From SARS-CoV-2 variants B.1.351 and P.1 escape from neutralizing antibodies (2021) · cites this paper as Peng et al., 2020
In the citing paper
“T cell responses are detected after almost all SARS-CoV-2 infections (Grifoni et al., 2020; Rydyznski Moderbacher et al., 2020; Peng et al., 2020; Sekine et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“In SARS-CoV-2 infections, the presence of virus-specific CD8+ T cells has been associated with better COVID-19 outcomes (Rydyznski Moderbacher et al., 2020; Peng et al., 2020).”
From Adaptive immunity to SARS-CoV-2 and COVID-19 (2021) · cites this paper as Peng et al., 2020
In the citing paper
“Current evidence suggests an early, robust, and diverse T cell response directed against SARS-CoV-2 correlates with milder COVID-19 outcomes126,131,132”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“Severe COVID-19 has been associated with lower TCR diversity against SARS-CoV-2 epitopes131,132.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
In the citing paper
“For CD8+ T cells, there are reports of diminished CD8+ cytotoxicity and cytokine production in severe cases126,132, while others report the opposite141, and still others find no differences142.”
From SARS-CoV-2, COVID-19 and the aging immune system (2021) · cites this paper as [132]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China
Huang, C., Wang, Y., Li, X., Ren, L., Zhao, J., Hu, Y., Zhang, L., Fan, G., Xu, J., Gu, X., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)30183-5 · Cited by 48,884
Clinical characteristics of coronavirus disease 2019 in China
Guan, W.-J., Ni, Z.-Y., Hu, Y., Liang, W.-H., Ou, C.-Q., He, J.-X., Liu, L., Shan, H., Lei, C.-L., Hui, D. S. C., et al. (2020) · New England Journal of Medicine · doi:10.1056/nejmoa2002032 · Cited by 30,246
Self-citationCryo-EM structure of the 2019-nCoV spike in the prefusion conformation
Wrapp, D., Wang, N., Corbett, K. S., Goldsmith, J. A., Hsieh, C.-L., Abiona, O., Graham, B. S., & McLellan, J. S. (2020) · Science · doi:10.1126/science.abb2507 · Cited by 8,897
Pathological findings of COVID-19 associated with acute respiratory distress syndrome
Xu, Z., Shi, L., Wang, Y., Zhang, J., Huang, L., Zhang, C., Liu, S., Zhao, P., Liu, H., Zhu, L., et al. (2020) · The Lancet Respiratory Medicine · doi:10.1016/s2213-2600(20)30076-x · Cited by 8,545
Coronaviruses: An Overview of Their Replication and Pathogenesis
Fehr, A. R., & Perlman, S. M. (2015) · Methods in molecular biology · doi:10.1007/978-1-4939-2438-7_1 · Cited by 3,910
Grifoni, A., Weiskopf, D., Ramirez, S. I., Mateus, J., Dan, J. M., Moderbacher, C. R., Rawlings, S. A., Sutherland, A., Premkumar, L., Jadi, R. S., et al. (2020) · Cell · doi:10.1016/j.cell.2020.05.015 · Cited by 3,595
High expression of ACE2 receptor of 2019-nCoV on the epithelial cells of oral mucosa
Xu, H., Zhong, L., Deng, J., Peng, J., Dan, H., Zeng, X., Li, T., & Chen, Q. (2020) · International Journal of Oral Science · doi:10.1038/s41368-020-0074-x · Cited by 2,838
Single-cell landscape of bronchoalveolar immune cells in patients with COVID-19
Liao, M., Liu, Y., Yuan, J., Wen, Y., Xu, G., Zhao, J., Cheng, L., Li, J., Wang, X., Wang, F., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-0901-9 · Cited by 2,614
Reduction and Functional Exhaustion of T Cells in Patients With Coronavirus Disease 2019 (COVID-19)
Diao, B., Wang, C., Tan, Y., Chen, X., Liu, Y., Ning, L., Chen, L., Li, M., Liu, Y., Wang, G., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.00827 · Cited by 2,475
Self-citationFolegatti, P. M., Ewer, K. J., Aley, P. K., Angus, B., Becker, S., Belij-Rammerstorfer, S., Bellamy, D., Bibi, S., Bittaye, M., Clutterbuck, E. A., et al. (2020) · The Lancet · doi:10.1016/s0140-6736(20)31604-4 · Cited by 2,419
Self-citation
Research works printed but not linked: 1
- Fehr, A. R. & Perlman, S. in Coronaviruses. Methods in Molecular Biology Vol. 1282 (eds Maier H., Bickerton E., Britton P.) 1–23 (Humana Press, 2015).
Cited by
Sorted by citations
Items 901–1,000 of 1,000
A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host
Minakshi, R., Jan, A. T., Rahman, S., & Kim, J. (2020) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2020.575404 · Cited by 4
COVID-19 molecular level laboratory diagnoses
Pohanka, M. (2021) · Bratislavské lekárske listy/Bratislava medical journal · doi:10.4149/bll_2021_025 · Cited by 4
Jeewandara, C., Guruge, D., Pushpakumara, P. D., Kamaladasa, A., Aberathna, I. S., Ramu, S. T., Gunasekera, B., Wijesinghe, A., Dissanayake, O., Kuruppu, H., et al. (2021) · The Journal of Immunology · doi:10.4049/jimmunol.2100762 · Cited by 4
Self-citationZhang, Y., Rogers, A. J., Nadeau, K. C., Gu, J., & Yang, S. S. (2021) · Frontiers in Public Health · doi:10.3389/fpubh.2021.638316 · Cited by 4
Self-citationSelection and T-cell antigenicity of synthetic long peptides derived from SARS-CoV-2
Piadel, K., Haybatollahi, A., Dalgleish, A. G., & Smith, P. L. (2022) · Journal of General Virology · doi:10.1099/jgv.0.001698 · Cited by 4
Analysis of Genomic Characteristics of SARS-CoV-2 in Italy, 29 January to 27 March 2020
Presti, A. L., Martino, A. D., Faggioni, G., Giordani, F., Fillo, S., Anselmo, A., Fain, V. V., Fortunato, A., Petralito, G., Molinari, F., et al. (2022) · Viruses · doi:10.3390/v14030472 · Cited by 4
Plummer, J., Contreras, D. A., Zhang, W., Binek, A., Zhang, R., Dezem, F. S., Chen, S. S., Davis, B. D., Martínez, J., Stotland, A. B., et al. (2022) · Clinical Infectious Diseases · doi:10.1093/cid/ciac295 · Cited by 3
da Silva, H. B. (2021) · ImmunoHorizons · doi:10.4049/immunohorizons.2000102 · Cited by 4
Immunogenic SARS-CoV2 Epitopes Defined by Mass SpectrometryPreprint
Pan, K., Chiu, Y., Huang, E. L., Chen, M. M., Wang, J., Lai, I. P., Singh, S., Shaw, R., MacCoss, M. J., & Yee, C. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.20.453160 · Cited by 4
Jabbour, G., Rego, S., Nguyenkhoa, V., & Dakshanamurthy, S. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.09.11.459907 · Cited by 4
Alexander, J. L., Liu, Z., Sandoval, D. M., Reynolds, C. J., Ibraheim, H., Anandabaskaran, S., Saifuddin, A., Seoane, R., Anand, N., Nice, R., et al. (2022) · SSRN Electronic Journal · doi:10.2139/ssrn.4172071 · Cited by 4
Pre-existing T Cell Memory to Novel Pathogens
Afroz, S., Bartolo, L., & Su, L. F. (2023) · ImmunoHorizons · doi:10.4049/immunohorizons.2200003 · Cited by 3
van den Dijssel, J., Konijn, V. A. L., Duurland, M. C., de Jongh, R., Koets, L., Veldhuisen, B., Raaphorst, H., Turksma, A. W., Heeren, J. J. F., Steenhuis, M., et al. (2025) · European Journal of Immunology · doi:10.1002/eji.202451565 · Cited by 3
Haltaufderhyde, K. D., Gutiérrez, A. H., McAllister, M., Boyle, C., Moise, L., Martin, W. D., & Groot, A. S. D. (2025) · Human Vaccines & Immunotherapeutics · doi:10.1080/21645515.2025.2501844 · Cited by 4
Patel, R. S., & Agrawal, B. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1619882 · Cited by 3
Natural and hybrid immunity: A comparative study of T cell response against SARS-CoV-2
de Andrade, A. G., Comberlang, F. C., Peixoto, R. F., Palmeira, P. H. D. S., Aureliano, F. S., Csordas, B. G., Silva, L. H. A. C., & Keesen, T. S. L. (2025) · Clinical Immunology Communications · doi:10.1016/j.clicom.2025.07.001 · Cited by 5
Jiang, W., Li, L., Xue, W., He, X., Chu, X., Song, L., Li, X., Zhao, R., Yuan, X., Jin, X., et al. (2026) · mAbs · doi:10.1080/19420862.2026.2624881 · Cited by 3
Jiang, S., Yuan, J., Li, Q., Song, Z., Cao, L., Song, Z., & Zhang, X. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1762041 · Cited by 3
SARS-CoV-2-Specific Adaptive Immunity in COVID-19 Survivors With Asthma
Chen, L., Yue, J., Zhang, S., Bai, W., Qin, L., Zhang, C., Wu, B., Li, M., Xu, S., Jiang, Q. Y., et al. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.947724 · Cited by 3
Bukreieva, T., Kyryk, V. M., Nikulina, V. V., Svitina, H. M., Vega, A., Chybisov, O., Shablii, I., Mankovska, O. S., Lobyntseva, G., Nemtinov, P., et al. (2023) · Biomedical Reports · doi:10.3892/br.2023.1615 · Cited by 3
Cellular immunity reflects the persistent symptoms among COVID-19 recovered patients in Japan
Miyata, Y., Suzuki, K., Nagano, T., Iida, K., Hasegawa, T., Uga, H., & Matsuoka, H. (2023) · Scientific Reports · doi:10.1038/s41598-023-35505-w · Cited by 3
Lopes-Ribeiro, Á., Oliveira, P. D. M., Retes, H. M., Barbosa‐Stancioli, E. F., da Fonseca, F. G., Tsuji, M., & Coelho-dos-Reis, J. G. A. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1229712 · Cited by 3
Sánchez-Menéndez, C., de la Calle‐Jiménez, O., Mateos, E., Vigón, L., Fuertes, D., Antón, M. A. M., José, E. S., García‐Gutiérrez, V., Cervero, M., Torres, M., et al. (2024) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1431411 · Cited by 3
Wang, L., Xu, R., Huang, D., Peng, P., Sun, K., Hu, J., Liu, B., Fang, L., Zhang, L., Sun, X., et al. (2024) · Communications Biology · doi:10.1038/s42003-024-07048-x · Cited by 2
Zornikova, K. V., Dianov, D. V., Ivanova, N. O., Davydova, V. D., Nenasheva, T. A., Fefelova, E. I., & Васильевна, Б. А. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms252312591 · Cited by 3
Zhang, Y.-W., Han, S., Sun, Q., Liu, T., Wen, Z., Yao, M., Zhang, S., Duan, Q., Zhang, X., Pang, B., et al. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1460442 · Cited by 3
Self-citationAging and Viral Evolution Impair Immunity Against Dominant Pan‐Coronavirus‐Reactive T Cell Epitope
Loyal, L., Jürchott, K., Reimer, U., Meyer‐Arndt, L., Henze, L., Mages, N., Kostrzanowski, J., Reus, B., Mangold, M., Kruse, B., et al. (2025) · European Journal of Immunology · doi:10.1002/eji.202551888 · Cited by 3
Tay, G., Niazi, S., He, C., Morawska, L., Bell, S. C., Spann, K. M., & Ristovski, Z. (2025) · Journal of Hospital Infection · doi:10.1016/j.jhin.2025.07.005 · Cited by 3
de Macêdo, L. S., Espinoza, B. C. F., Invenção, M. D. C. V., de Pinho, S. S., Leal, L. R. S., Silva, M. E. D. S., Bandeira, B. M. A., Novis, P. V. S., Souza, T. H. D. S., Maux, J. M. D. L., et al. (2025) · Infectious Disease Reports · doi:10.3390/idr17050104 · Cited by 3
Rigo, M., Fasoulis, R., Conev, A., Hall-Swan, S., Antunes, D. A., & Kavraki, L. E. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.931155 · Cited by 3
Fallet, B., Foglierini, M., Porret, R., Alcaraz‐Serna, A., Sauvage, C., Jenelten, R., Seremet, T., Gilliet, M. F., Perez, L. H., Fenwick, C. W., et al. (2023) · Journal of Infection · doi:10.1016/j.jinf.2023.06.005 · Cited by 4
Verheul, M. K., Vos, M. W., de Rond, L., de Zeeuw‐Brouwer, M., Nijhof, K. H., Smit, D., Oomen, D., Molenaar, P., Bogaard, M., van Bergen, R., et al. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1327875 · Cited by 3
Wolz, O., Vahrenhorst, D., Quintini, G., Lemberg, C., Koch, S. D., Kays, S.-K., Walz, L., Kulkarni, N., Fehlings, M., Wengenmayer, P., et al. (2024) · Vaccines · doi:10.3390/vaccines12040388 · Cited by 3
Vanamudhu, A., Arumugam, R. D., Nancy, A., Selvaraj, N., Moideen, K., Hissar, S. S., Ranganathan, U. D., Bethunaickan, R., Babu, S., & Kumar, N. P. (2024) · Viruses · doi:10.3390/v16081178 · Cited by 3
Yao, D., Patel, R. S., Lam, A., Glover, Q., Srinivasan, C., Herchen, A., Ritchie, B. C., & Agrawal, B. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25189814 · Cited by 3
T-cell immunobiology and cytokine storm of COVID-19
Eltayeb, A., & Redwan, E. M. M. M. (2025) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2024.10.003 · Cited by 4
Ocular neuroinflammatory response secondary to SARS-CoV-2 infection-a review
Zhao, Y., Tang, Y., Wang, Q. Y., & Li, J. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2025.1515768 · Cited by 6
Self-citationZheng, H., Chen, Y., Li, J., Zhang, Y., Li, H., Zhao, X., He, Z., Liao, Y., Zhang, Z., Shi, H., et al. (2025) · Molecular Therapy · doi:10.1016/j.ymthe.2025.05.031 · Cited by 2
Self-citationInsights into the virologic and immunologic features of SARS-COV-2
Polat, C., & Ergünay, K. (2021) · World Journal of Clinical Cases · doi:10.12998/wjcc.v9.i19.5007 · Cited by 3
The impact of lymphoid memory cells in different ages of COVID-19 patients
Jafari, M., Kolahdooz, H., Mahmoudi, M., Azarnaminy, A. F., Mobasheri, L., & Esmaeili, S. (2022) · Gene Reports · doi:10.1016/j.genrep.2022.101503 · Cited by 3
Differences in Characteristics of T-Cell Immunity to SARS-CoV-2 in Clinically Healthy Subjects
Николаевна, С. Н., Попов, О. С., Полковникова, И. А., Al’pako, S. V., & Shcherbak, S. G. (2022) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-022-05508-0 · Cited by 3
Long term SARS-CoV-2-specific cellular immunity after COVID-19 in liver transplant recipients
Citores, M. J., Marcos, A., Cuervas‐Mons, V., Alonso, R., Morales, J. G., Arias‐Milla, A., Valerio, M., Muñóz, P., & Salcedo, M. (2023) · Journal of Microbiology Immunology and Infection · doi:10.1016/j.jmii.2023.03.003 · Cited by 3
Maple, P. A. C. (2021) · Vaccines · doi:10.3390/vaccines9060550 · Cited by 3
Antiviral Immunity in SARS-CoV-2 Infection: From Protective to Deleterious Responses
Mihăescu, G., Chifiriuc, M. C., Vrâncianu, C. O., Constantin, M., Filip, R., Popescu, M. R., Burlibaşa, L., Nicoară, A. C., Bolocan, A., Iliescu, C., et al. (2021) · Microorganisms · doi:10.3390/microorganisms9122578 · Cited by 3
Sedegah, M., Porter, C. K., Hollingdale, M. R., Ganeshan, H. D., Huang, J., Goforth, C. W., Belmonte, M., Belmonte, A. D., Weir, D. L., Lizewski, R. A., et al. (2022) · PLoS ONE · doi:10.1371/journal.pone.0266691 · Cited by 4
Longitudinal monitoring of SARS-CoV-2 spike protein-specific antibody responses in Lower Austria
Rebholz, H., Braun, R. J., Saha, T., Harzer, O., Schneider, M., & Ladage, D. (2022) · PLoS ONE · doi:10.1371/journal.pone.0271382 · Cited by 3
Reimann, H., Moosmann, C., Schober, K., Lang, V., Verhagen, J., Zeun, J., Mackensen, A., Kremer, A. N., Völkl, S., & Aigner, M. (2023) · Immunobiology · doi:10.1016/j.imbio.2023.152720 · Cited by 2
Heterogeneous immunological recovery trajectories revealed in post-acute COVID-19Preprint
Su, Y., Yuan, D., Chen, D. G., Wang, K., Choi, J., Dai, C. L., Hong, S., Zhang, R., Xie, J., Li, S., et al. (2021) · medRxiv · doi:10.1101/2021.03.19.21254004 · Cited by 3
Diversity of vaccination-induced immune responses can prevent the spread of vaccine escape mutantsPreprint
Bouman, J. A., Capelli, C., & Regoes, R. R. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.04.14.439790 · Cited by 3
Waning immune responses against SARS-CoV-2 among vaccinees in Hong KongPreprint
Peng, Q., Zhou, R., Wang, Y., Zhao, M., Liu, N., Li, S., Huang, H., Yang, D., Au, K., Wang, H., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.12.22.473934 · Cited by 3
Coulon, P.-G. A., Prakash, S., Dhanushkodi, N. R., Srivastava, R., Zayou, L., Tifrea, D. F., Edwards, R. A., Cesar, J. F., Schubl, S. D., Hsieh, L. L., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.01.30.478343 · Cited by 4
Memory cytotoxic SARS-CoV-2 spike protein-specific CD4+ T cells associate with viral controlPreprint
Dong, T., Liu, G., Felce, S. L., Yao, X., Yin, Z., Fries, A., Mentzer, A. J., Dong, D., Wang, W., Dejnirattisai, W., et al. (2022) · Research Square · doi:10.21203/rs.3.rs-1317569/v1 · Cited by 3
Self-citationAn ACAT inhibitor regulates SARS-CoV-2 replication and antiviral T cell activityPreprint
Schmidt, N. M., Wing, P. A. C., Peters, R., Brown, R. L., Wang, H., Swadling, L., COVIDsortium Investigators, Newman, J., Thakur, N., Shionoya, K., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.12.487988 · Cited by 3
SARS-CoV-2 mutations affect proteasome processing to alter CD8 + T cell responsesPreprint
Wellington, D., Yin, Z., Yu, Z., Heilig, R., Davis, S. A., Fischer, R., Felce, S. L., Hublitz, P., Beveridge, R. D. D., Dong, D., et al. (2022) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2022.04.08.487623 · Cited by 3
Self-citationBilich, T., Nelde, A., Heitmann, J. S., Maringer, Y., Roerden, M., Bauer, J., Rieth, J., Wacker, M., Peter, A., Hörber, S., et al. (2020) · SSRN Electronic Journal · doi:10.2139/ssrn.3713528 · Cited by 2
COVID-19 Animal Models and Vaccines: Current Landscape and Future Prospects
Wang, S., Li, L., Yan, F., Gao, Y., Yang, S., & Xia, X. (2021) · Vaccines · doi:10.3390/vaccines9101082 · Cited by 2
Čuperlović‐Culf, M., Bennett, S. A. L., Galipeau, Y., McCluskie, P. S., Arnold, C. R., Bagheri, S., Cooper, C., Langlois, M., Fritz, J. H., Piccirillo, C. A., et al. (2024) · iScience · doi:10.1016/j.isci.2024.110484 · Cited by 2
Lalinde-Ruiz, N., Martínez-Enriquez, L. C., Gutierrez, D. A., Nieto, H. H., Niño, L. F., & Parra-López, C. (2025) · Computational Biology and Chemistry · doi:10.1016/j.compbiolchem.2025.108389 · Cited by 3
Natural Infection of Omicron BA.5.2 in Patients Provides Broad Immune Responses Against SARS-CoV-2
Li, L., Feng, T., Shen, Q., Shi, X., Wei, Z., Chen, W., Yang, F., Zhu, Y., Zhang, C., Zhang, S., et al. (2025) · Microorganisms · doi:10.3390/microorganisms13040746 · Cited by 2
Ascertaining the mechanistic etiology of COVID-associated glomerulonephritis: a systematic review
Coyne, B. J., Ito, D., Tariq, A., Lew, S. Q., Kopp, J. B., Centron, P., Malik, F., Gipson, P. E., & Nobakht, E. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1568943 · Cited by 2
Lung-resident SARS-CoV-2 peptide-specific immune responses in perfused 3D human lung explant models
Goliwas, K. F., Wood, A. M., Simmons, C. S., Khan, R., Khan, S. A., Wang, Y., Ramachandran, R., Berry, J. L., Athar, M., Mobley, J. A., et al. (2025) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2025.1587080 · Cited by 2
Goto, Y., Ahn, Y. M., Toyoda, M., Hamana, H., Jin, Y., Aritsu, Y., Nakama, T., Tajima, Y., Maddumage, J. C., Li, H. Z., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-63288-3 · Cited by 2
Mitić, I., Glamočlija, S., Ilić, N., Sabljić, L., Tomić, S., Gruden‐Movsesijan, A., & Sofronić‐Milosavljević, L. (2025) · Memórias do Instituto Oswaldo Cruz · doi:10.1590/0074-02760250044 · Cited by 3
Malik, S. A., Modarage, K., & Goggolidou, P. (2022) · F1000Research · doi:10.12688/f1000research.122820.2 · Cited by 2
Microbiome characteristics description of COVID-19 patients based on bulk RNA-seq and scRNA-Seq data
Zhang, S., Liu, X., Zhao, Y., Wang, P., Yu, R., Xu, P., Jiang, Y., & Cheng, L. (2023) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2023.107400 · Cited by 2
Self-citationLandscape of infiltrated immune cell characterization in COVID-19
Zheng, W., Zhang, Y., Lai, G., & Xie, B. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28174 · Cited by 2
Self-citationScientific highlights of the 9th ESWI Influenza Conference
Reperant, L. A., Russell, C. A., & Osterhaus, A. D. M. E. (2024) · One Health Outlook · doi:10.1186/s42522-024-00099-4 · Cited by 2
Vladimirov, I. S., Zhdanova, A. S., Евгеньевич, М. В., Makarov, V. V., Yudin, V. S., & Александрович, К. С. (2023) · Medical Immunology (Russia) · doi:10.15789/1563-0625-iaf-2921 · Cited by 2
Xu, X., Huang, J., Zhang, H., Lu, W., & Liu, J. (2024) · Immunity Inflammation and Disease · doi:10.1002/iid3.1281 · Cited by 2
The Development of Epitope-Based Recombinant Protein Vaccines against SARS-CoV-2
Khalid, K., Lim, H. X., Hwang, J. S., & Poh, C. L. (2024) · The AAPS Journal · doi:10.1208/s12248-024-00963-1 · Cited by 3
Coronaviruses: Pandemic SARS-CoV-2
Cowling, B. J., & Wong, S. (2024) · Springer eBooks · doi:10.1007/978-1-4939-9544-8_68-1 · Cited by 2
Raineri, D., Mazzucca, C. B., Moia, R., Bruna, R., Kuštrimović, N. Z., Cappellano, G., Bellan, M., Perazzi, M., Gaïdano, G., & Chiocchetti, A. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126723 · Cited by 3
The trend of phylogenetic and epitope variations of SARS-CoV-2 Omicron sub-lineages in Iran
Shabani, M., Nejati, A., Yavarian, J., Sadeghi, K., Zadheidar, S., Ahmadi, A. S., Ghadirali, M., Zebardast, A., Abedi, A., Najmi, M. H., et al. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2024.1531712 · Cited by 2
Hao, T., RYAN, G. E., Lydeamore, M., Cromer, D., Wood, J. G., McVernon, J., McCaw, J. M., Shearer, F. M., & Golding, N. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.126987 · Cited by 3
COVID-19 mRNA or viral vector vaccine type and subject sex influence the SARS-CoV-2 T-cell response
Tong, S., Litwin, S. M., Epel, E. S., Lin, J., Drury, S. S., Hecht, F. M., Robinson, J. E., Prather, A. A., & Norton, E. B. (2025) · Vaccine · doi:10.1016/j.vaccine.2025.127420 · Cited by 2
Yu, G., & Huang, H. (2025) · Frontiers in Microbiology · doi:10.3389/fmicb.2025.1551320 · Cited by 3
An Overview About the Role of Adaptive Immunity in Keeping SARS-CoV-2 Reinfections at Bay
Ahsan, H., Sonn, J. K., Lee, Y. S., Islam, S. U., & Khalil, S. K. (2021) · Viral Immunology · doi:10.1089/vim.2021.0017 · Cited by 2
Recent SARS-CoV-2 Outlook and Implications in a COVID-19 Vaccination Era
Ehianeta, T. S., Mzee, S. A. S., Kehinde, A. M., & Ehianeta, O. (2021) · Infectious Microbes & Diseases · doi:10.1097/im9.0000000000000072 · Cited by 2
Lagedal, R., Eriksson, O., Sörman, A., Huckriede, J., Kristensen, B. W., Franzén, S., Larsson, A. O., Bergqvist, A., Alving, K., Forslund, A. H., et al. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11123419 · Cited by 3
Deng, X., Zhang, Y., Li, M., Tang, X., Chen, Y., Chen, Y., Zhao, Y., Wen, Q., Wu, X., Li, J., et al. (2022) · International Journal of Biological Sciences · doi:10.7150/ijbs.71163 · Cited by 2
Self-citationSprečo, A., Dahlström, Ö., Jöud, A., Nordvall, D., Fagerström, C., Blomqvist, E., Gustafsson, F., Hinkula, J., Schön, T. B., & Timpka, T. (2022) · Vaccines · doi:10.3390/vaccines10081273 · Cited by 2
The need for more holistic immune profiling in next-generation SARS-CoV-2 vaccine trials
Murphy, R. L., Paramithiotis, E., Sugden, S., Chermak, T., Lambert, B. L., Montamat‐Sicotte, D., Mattison, J. E., & Steinhubl, S. R. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.923106 · Cited by 2
Gurevich, M., Zilkha‐Falb, R., Sonis, P., Magalashvili, D., Dolev, M., Mandel, M., Menascu, S., & Achiron, A. (2022) · Pediatric Allergy and Immunology · doi:10.1111/pai.13863 · Cited by 1
Beltz, L. A. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-98809-4.00013-9 · Cited by 2
Evaluation of T and B cell immunophenotyping and antibody response post Covid-19 vaccination
Chadha, R., Udayakumar, D., Phogat, R., Alam, S., Mathur, N., Singh, M. K., Kataria, S., Sharma, P., Singh, P., Sarma, S., et al. (2023) · Indian Journal of Medical Microbiology · doi:10.1016/j.ijmmb.2023.100372 · Cited by 2
A Review on Role of Inflammation in Coronavirus Disease
Lotfi, A., Hajian, P., Abbasi, L., Gargari, M. K., Fard, N. N. G., & Naderi, D. (2024) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/0118715303265274231204075802 · Cited by 2
Impact of Chronic HIV Infection on Acute Immune Responses to SARS-CoV-2
Opsteen, S., Fram, T., Files, J. K., Levitan, E. B., Goepfert, P., & Erdmann, N. B. (2024) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000003399 · Cited by 2
Humoral and Cellular Immune Response to SARS-CoV-2 S and N Proteins
Afridonova, Z. E., Топтыгина, А. П., & Mikhaylov, I. S. (2024) · Biochemistry (Moscow) · doi:10.1134/s0006297924050080 · Cited by 2
Domenico, M. D., Serretiello, E., Smimmo, A., Silva, F. F. V. E., Raimondi, S. A., Pascariello, C., Marino, M. M., Muzio, L. L., Caponio, V. C. A., Cantore, S., et al. (2024) · Journal of Personalized Medicine · doi:10.3390/jpm14070733 · Cited by 2
SARS-CoV-2 Immunity: Review of Immune Response to Infection and Vaccination
Ahmad, R. (2021) · Bangladesh Journal of Medical Science · doi:10.3329/bjms.v20i5.55398 · Cited by 2
Watson, M. E., Inagaki, K., & Weinberg, J. B. (2021) · Comparative Medicine · doi:10.30802/aalas-cm-21-000011 · Cited by 3
Maghsood, F., Hassani, D., Salimi, V., Kardar, G., Khoshnoodi, J., Ghaderi, A., Raeeskarami, S. R., Rostamian, A., Seyyedsalehi, M. S., Fesharaki, R. A., et al. (2021) · Viral immunology · doi:10.1089/vim.2021.0061 · Cited by 2
Aryanian, Z., Balighi, K., Afshar, Z. M., Zamanian, M. H., Razavi, Z., & Hatami, P. (2022) · Journal of Cosmetic Dermatology · doi:10.1111/jocd.15448 · Cited by 2
HLA class I genotypes customize vaccination strategies in immune simulation to combat COVID-19Preprint
Huang, S., & Tan, M. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.11.18.388983 · Cited by 2
Neurological complications of SARS-CoV-2 coronavirus infection (COVID-19)
Otruba, P., Bardoň, J., Kolář, M., Petroušová, L., Raška, M., Salzman, R. S., Dorňák, T., Hluštı́k, P., Hok, P., Hvizdošová, L., et al. (2020) · Neurologie pro praxi · doi:10.36290/neu.2020.121 · Cited by 2
Norheim, G., Stubsrud, E., Skullerud, L. M., Stankovic, B., Chellappa, S., Bjerkan, L., Kuczkowska, K., Müller, E., Sekelja, M., & Fredriksen, A. B. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.08.416875 · Cited by 2
Pre-Existing Cellular Immunity to SARS-CoV-2 Through an Immunodominant EpitopePreprint
Lineburg, K. E., Grant, E. J., Swaminathan, S., Chatzileontiadou, D. S. M., Szeto, C. W., Sloane, H., Panikkar, A., Raju, J., Crooks, P., Rehan, S., et al. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3774361 · Cited by 2
Sandberg, J. T., Varnaitė, R., Christ, W., Chen, P., Muvva, J. R., Maleki, K. T., García, M., Dzidic, M., Folkesson, E., Skagerberg, M., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.03.17.435581 · Cited by 2
Immunogenicity and pre-clinical efficacy of an OMV-based SARS-CoV-2 vaccinePreprint
Grandi, A., Tomasi, M., Bertelli, C., Vanzo, T., Gagliardi, A., Caproni, E., Tamburini, S., Fantappiè, L., Lascio, G. D., Bisoffi, Z., et al. (2021) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2021.07.12.452027 · Cited by 2
De novo design of anti-variant COVID-19 vaccine
Goswami, A., Kumar, M., Ullah, S., & Gore, M. M. (2023) · Biology Methods and Protocols · doi:10.1093/biomethods/bpad021 · Cited by 2
Metadata
- Authors
- Peng, Y., Mentzer, A. J., Liu, G., Yao, X., Yin, Z., Dong, D., Dejnirattisai, W., Rostron, T., Supasa, P., Liu, C., López-Camacho, C., Slon-Campos, J., Zhao, Y., Stuart, D. I., Paesen, G. C., Grimes, J. M., Antson, A. A., Bayfield, O. W., Hawkins, D. E. D. P., Ker, D.-S., Wang, B., Turtle, L., Subramaniam, K., Thomson, P., Zhang, P., Dold, C., Ratcliff, J., Simmonds, P., de Silva, T., Sopp, P., Wellington, D., Rajapaksa, U., Chen, Y.-L., Salio, M., Napolitani, G., Paes, W., Borrow, P., Kessler, B. M., Fry, J. W., Schwabe, N. F., Semple, M. G., Baillie, J. K., Moore, S. C., Openshaw, P. J. M., Ansari, M. A., Dunachie, S., Barnes, E., Frater, J., Kerr, G., Goulder, P., Lockett, T., Levin, R., Zhang, Y., Jing, R., Ho, L.-P., Oxford Immunology Network Covid-19 Response T cell Consortium, Barnes, E., Dong, D., Dong, T., Dunachie, S., Frater, J., Goulder, P., Kerr, G., Klenerman, P., Liu, G., McMichael, A., Napolitani, G., Ogg, G., Peng, Y., Salio, M., Yao, X., Yin, Z., ISARIC4C Investigators, Kenneth Baillie, J., Klenerman, P., Mentzer, A. J., Moore, S. C., Openshaw, P. J. M., Semple, M. G., Stuart, D. I., Turtle, L., Cornall, R. J., Conlon, C. P., Klenerman, P., Screaton, G. R., Mongkolsapaya, J., McMichael, A., Knight, J. C., Ogg, G., & Dong, T.
- Affiliations
- University of Oxford (GB)
- Centre for Human Genetics (GB)
- University of York (GB)
- University of Liverpool (GB)
- University of Sheffield (GB)
- ProImmune (United Kingdom) (GB)
- Oxford University Hospitals NHS Trust (GB)
- Worthing Hospital (GB)
- Capital Medical University (CN)
- University of Edinburgh (GB)
- Siriraj Hospital (TH)
- ORCID
- Dejnirattisai, Wanwisa
- Supasa, Piyada
- Liu, Chang
- López-Camacho, César
- Slon-Campos, Jose
- Zhao, Yuguang
- Paesen, Guido C.
- Grimes, Jonathan M.
- Antson, Alfred A.
- Bayfield, Oliver W.
- Hawkins, Dorothy E. D. P.
- Ker, De-Sheng
- Wang, Beibei
- Subramaniam, Krishanthi
- Thomson, Paul
- Zhang, Ping
- Dold, Christina
- Ratcliff, Jeremy
- Simmonds, Peter
- de Silva, Thushan
- Wellington, Dannielle
- Rajapaksa, Ushani
- Chen, Yi-Ling
- Paes, Wayne
- Borrow, Persephone
- Kessler, Benedikt M.
- Fry, Jeremy W.
- Ansari, M. Azim
- Zhang, Yonghong
- Ho, Ling-Pei
- Cornall, Richard J.
- Screaton, Gavin R.
- Mongkolsapaya, Juthathip
- Knight, Julian C.
- Venue
- Nature Immunology
- Published
- 2020-09-04
- Volume
- 21
- Issue
- 11
- Pages
- 1336-1345
- ISSN
- 1529-2908 (ISSN-L)
- 1529-2916
- PMC
- PMC7611020
- OpenAlex
- W3082438395
- Cited by
- 1,179
- References
- 42
- Citations by year
- 2026: 41 · 2025: 68 · 2024: 118 · 2023: 171 · 2022: 291 · 2021: 398 · 2020: 91
- FWCI
- 30.26
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Licence
- Locations
- Nature Immunology (publishedVersion)
- bioRxiv (Cold Spring Harbor Laboratory) (acceptedVersion)
- PubMed (publishedVersion)
- White Rose Research Online (University of Leeds, The University of Sheffield, University of York) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Oxford University Research Archive (ORA) (University of Oxford) (acceptedVersion)
- PubMed Central (submittedVersion)
- Funders
- RCUK | Medical Research Council (MC_PC_19059)
- Chinese Academy of Medical Sciences (2018-I2M-2-002)
- China Scholarship Council
- Wellcome Trust (205228/Z/16/Z, 110058/Z/15/Z, 215091/Z/18/Z, 095541/A/11/Z, award 206377 to AAA)
- DH | NIHR | Health Services Research Programme (NIHR200907, CO-CIN-01)
- University of Liverpool
- University of Oxford
- University of Edinburgh
- DH | National Institute for Health Research (NIHR200927 /WHRG_P82523, NIHR201385 / WHRR P84026, NIHR200907)
- Imperial College London (IS-BRC-1215-20013)
- Worthing Hospital
- Oxford University Hospitals NHS Trust
- National Institutes of Health, National Key R&D Program of China
- University of York
- ProImmune Ltd
- Bill and Melinda Gates Foundation (MC_PC_19059)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › vaccines and immunoinformatics approaches
- Life Sciences › Immunology and Microbiology › Immunology › T-cell and B-cell Immunology
- Keywords
- SARS-CoV-2, COVID-19 pandemic, T cell memory, CD4+ T cells, CD8+ T cells, epitope mapping, immunodominant epitopes, spike protein, disease severity, convalescent patients, central memory T cells, effector memory T cells, antiviral immunity
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
